In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through ...

Over the past 12 months, a number of medtech companies at various stages hauled in significant funding rounds to support ...

AngioDynamics sheds some catheter products in $45M ... include about one-third of men showing urinary leakage, and about 95% reporting erectile dysfunction lasting for years.

Testicular atrophy means the testes inside the scrotum ("ball sack") shrink. It is a treatable medical condition. Learn how ...

Studies reveal a connection between benign prostatic hyperplasia and erectile dysfunction ... Treatment of lower urinary tract symptoms (LUTS) secondary to BPH with the Optilume BPH Catheter System ...

The use of anticoagulants or indwelling urinary catheters for urinary retention ... 16 cases of liver or kidney dysfunction, 18 cases of diabetes and 15 cases of hypoproteinemia.

doi: 10.1002/nau.25556. Clean intermittent self-catheterisation (CISC) is a very common and largely well-tolerated intervention for people with neurological and urological voiding dysfunction; however ...

Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.

Artificial Intelligence (AI) has great potential in erectile dysfunction (ED) diagnosis and treatment. This review aims to summarize AI-based clinical decision-making in ED. Based on the literature ...

Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosisalfapump® is ...

Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis ...

I am a 63-year-old male in good health. A few weeks back, I could not urinate while standing. The only way I could was by laying on my ...